Arrowhead Pharmaceuticals Inc (ARWR) — Tangible Net Worth Ratio
Arrowhead Pharmaceuticals Inc (ARWR) has a Tangible Net Worth Ratio of 98.6% as of September 2025. This metric is calculated by deducting intangible assets ($6.86 Million) from net assets ($503.42 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore Arrowhead Pharmaceuticals Inc (ARWR) net asset momentum to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Arrowhead Pharmaceuticals Inc Tangible Net Worth Ratio (2003–2025)
This chart shows how Arrowhead Pharmaceuticals Inc's Tangible Net Worth Ratio has changed across 23 annual periods from 2003 to 2025. As of September 2025, the ratio stands at 98.6%, reflecting net assets of $503.42 Million with intangible assets of $6.86 Million USD. For live market cap and overall valuation, see Arrowhead Pharmaceuticals Inc (ARWR) market capitalisation.
Annual Tangible Net Worth Ratio for Arrowhead Pharmaceuticals Inc (2003–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Arrowhead Pharmaceuticals Inc from 2003 to 2025, covering 23 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. Explore ARWR capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 98.6% | $503.42 Million | $6.86 Million | $1.45 Billion | ▲ +3.1 pp |
| 2024 | 95.5% | $191.06 Million | $8.56 Million | $1.14 Billion | ▼ -0.9 pp |
| 2023 | 96.4% | $287.16 Million | $10.26 Million | $765.55 Million | ▼ -0.7 pp |
| 2022 | 97.1% | $418.34 Million | $11.96 Million | $691.94 Million | ▲ +0.5 pp |
| 2021 | 96.7% | $408.82 Million | $13.66 Million | $710.15 Million | ▼ 0.0 pp |
| 2020 | 96.7% | $461.78 Million | $15.36 Million | $522.50 Million | ▲ +3.7 pp |
| 2019 | 93.0% | $244.04 Million | $17.06 Million | $349.85 Million | ▲ +12.7 pp |
| 2018 | 80.3% | $95.24 Million | $18.76 Million | $111.61 Million | ▲ +5.6 pp |
| 2017 | 74.7% | $80.87 Million | $20.46 Million | $104.02 Million | ▼ -2.0 pp |
| 2016 | 76.7% | $95.02 Million | $22.16 Million | $128.18 Million | ▼ -0.7 pp |
| 2015 | 77.4% | $109.62 Million | $24.82 Million | $132.27 Million | ▼ -22.0 pp |
| 2014 | 99.4% | $165.99 Million | $1.01 Million | $182.82 Million | ▲ +12.0 pp |
| 2013 | 87.4% | $25.73 Million | $3.24 Million | $37.33 Million | ▲ +41.7 pp |
| 2012 | 45.7% | $8.81 Million | $4.78 Million | $16.53 Million | ▼ -40.5 pp |
| 2011 | 86.2% | $12.56 Million | $1.73 Million | $15.89 Million | ▲ +11.6 pp |
| 2010 | 74.7% | $8.08 Million | $2.05 Million | $12.35 Million | ▲ +23.3 pp |
| 2009 | 51.4% | $4.86 Million | $2.36 Million | $7.70 Million | ▼ -26.3 pp |
| 2008 | 77.7% | $12.30 Million | $2.75 Million | $17.26 Million | ▼ -11.2 pp |
| 2007 | 88.9% | $26.46 Million | $2.94 Million | $29.85 Million | ▼ -0.5 pp |
| 2006 | 89.4% | $31.61 Million | $3.35 Million | $34.53 Million | ▲ +1.1 pp |
| 2005 | 88.3% | $28.02 Million | $3.28 Million | $29.04 Million | ▼ -2.2 pp |
| 2004 | 90.5% | $11.23 Million | $1.06 Million | $11.92 Million | ▼ -9.5 pp |
| 2003 | 100.0% | $1.42 Million | $0.00 | $1.52 Million | — |